NCT04478279 2026-02-09
A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
Sapience Therapeutics
Phase 1/2 Active not recruiting
Sapience Therapeutics
Hoffmann-La Roche
BeiGene
Eli Lilly and Company
Eli Lilly and Company
Boneca Corporation